FDA Investigator Monica E Caphart
Monica E Caphart has conducted inspections on 6 sites in 5 countries as of 08 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
08 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Ireland,
United Kingdom of Great Britain and Northern Ireland,
France,
Switzerland,
Canada
FDA Investigators that have inspected at least one site in common with Monica E Caphart:
Anita R Michael,
Ann L Demarco,
Aurora Miha Trifanov,
Azza Talaat,
Brian L Belz,
Charisse K Green,
Charles M Edwards,
Debra J Bennett,
Djamila Harouaka,
Dr. Sriram Subramaniam, PhD,
Eileen A Liu,
Felix Maldonado,
Francis A Guidry,
Hala L Selby,
Ivis L Negron,
James C Maclaughlin,
James P Mcevoy,
James P Mcreavey,
Jose Acruz Gonzalez,
Katherine Szestypalow,
Kham Phommachanh,
Kristin M Abaonza,
Kristy A Zielny,
Kristy E Zuroski,
Latorie S Jones,
Laurimer Kuilan Torres,
Lequita M Mayhew,
Lloyd D Payne,
Marian E Ramirez,
Mark E Parmon,
Marybet Lopez Negron,
Matthew C Watson,
Michael J Kuchta,
Michael R Goga,
Miguel A Martinez Perez,
Mra Mcculloughj,
Parul M Patel,
Richard Ledwidge (nmi), PhD,
Robert M Barbosa,
Roy R Rinc,
Russell J Glapion,
S Lori Brown, PhD MPH,
Sarah E Mcmullen,
Sarmistha Sanyal, PhD,
Simone E Pitts,
Stephen D Eich,
Steven M Weinman,
Susanne M Richardson, MS RAC,
Timothy T Kapsala,
Truong Xuan Nguyen (Andy),
Walden H Lee
Monica E Caphart's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2004 | FDA 483 | Germiphene Corporation - Form 483, 2004-10-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more